Current Report Filing (8-k)
March 18 2022 - 04:25PM
Edgar (US Regulatory)
0001671818false00016718182022-03-152022-03-15
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
|
|
Date of Report (Date of earliest event reported):
March 15, 2022
|
ONCORUS, INC.
(Exact name of Registrant as Specified in Its Charter)
|
|
|
|
|
|
Delaware
|
001-39575
|
47-3779757
|
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
|
|
|
|
|
|
50 Hampshire Street
Suite 401
|
|
|
Cambridge,
Massachusetts
|
|
02139
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
|
|
Registrant’s Telephone Number, Including Area Code:
(857)
320-6400
|
(Former Name or Former Address, if Changed Since Last
Report)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
☐Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
☐Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
☐Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
☐Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
|
|
|
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange on which registered
|
|
Common Stock, $0.0001 par value per share
|
|
ONCR
|
|
The NASDAQ Stock Market LLC
|
Indicate by check mark whether the registrant is an emerging growth
company as defined in Rule 405 of the Securities Act of 1933
(§ 230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange
Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of
Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
On March 15, 2022, John McCabe notified Oncorus, Inc. (the
"Company") of his intention to resign as Chief Financial Officer
and Treasurer of the Company, effective April 1, 2022, to pursue an
opportunity with a private company. Mr. McCabe's resignation does
not result from any disagreement with the Company on any matter
relating to the Company's operations, policies and practices.
Theodore (Ted) Ashburn, the Company's Chief Executive Officer,
commented, "John has played a key role in Oncorus' growth,
including through our Series B financing and the closing of our
IPO, but we understand his interest in pursuing this new
opportunity. On behalf of the entire company, we thank and wish him
the very best."
In connection with Mr. McCabe's resignation, the Company and Mr.
McCabe intend to enter into a Consulting Agreement (the "McCabe
Agreement") pursuant to which, among other things, following April
1, 2022, Mr. McCabe will provide advisory services to the Company
for a period of up to six months (the "Advisory Period"). As
consideration for Mr. McCabe's advisory services, Mr. McCabe will
be paid an hourly rate and his outstanding equity awards will
continue to vest during the Advisory Period.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
|
|
|
|
|
|
|
|
ONCORUS, INC.
|
|
|
|
|
|
|
Date:
|
March 18, 2022
|
By:
|
/s/ Ted Ashburn
|
|
|
|
|
Theodore (Ted) Ashburn, M.D., Ph.D.
President and Chief Executive Officer
|
Oncorus (NASDAQ:ONCR)
Historical Stock Chart
From Sep 2022 to Oct 2022
Oncorus (NASDAQ:ONCR)
Historical Stock Chart
From Oct 2021 to Oct 2022
